A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer
Kelly, R. J., Thomas, A., Rajan, A., Chun, G., Lopez-Chavez, A., Szabo, E., Spencer, S., Carter, C. A., Guha, U., Khozin, S., Poondru, S., Van Sant, C., Keating, A., Steinberg, S. M., Figg, W., GiaccoVolume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt249
Date:
October, 2013
File:
PDF, 198 KB
english, 2013